fusidic acid

REMS

Topical Local treatment of primary and secondary bacterial skin infections including impetigo contagiosa, erythrasma and secondary skin infections such as infected wounds/burns.
Treatment of superficial eye infections.

Contraindicated in:

Hypersensitivity to fusidic acid or other components of the formulation (topical ointment contains lanolin).

Use Cautiously in:

OB: Potential benefits should be weighed against the possible hazards to the fetus (crosses the placenta);
Lactation: Safe use during breastfeeding has not been established (enters breast milk).

Derm: mild local irritation

Drug-drug:

(Adults and Children ): Apply to affected area 3–4 times daily.
(Adults and Children ): One drop into conjunctival sac of both eyes every 12 hr for 7 days.

Therapeutic effects:

Resolution of localized bacterial infections.
Not active against Gram-negative organisms; active against Staphylococci, Streptococci, and Corynebacterium.

Therapeutic Classification: anti-infectives

Absorption: Unknown.

Distribution: Systemically absorbed drug crosses the placenta and enters breast milk.

Metabolism/Excretion: Absorbed drug is extensively metabolized.

Half-Life: 5–6 hr.

Fucidin, Fucithalmic

ROUTE	ONSET	PEAK	DURATION
Top	unknown	unknown	6–8 hr
Ophth	unknown	unknown	12 hr

Instruct patient to apply medication as directed for full course of therapy, even if feeling better. Emphasize the importance of avoiding the eyes.
Advise patient to report increased skin irritation or lack of response to therapy to health care professional.

fyoo-SID-ik AS-id